A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
Clinical trial NCT05834244 · RECRUITING
Trial details
- NCT number
- NCT05834244
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-26
- Primary completion
- 2028-06-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.